BackAcorda Therapeutics Overview

Acorda Therapeutics Total Revenue

Revenue analysis for ACOR.

Quarterly Revenue

$20.29M
↓ 8.85% YoY

As of Mar 2024

Annual Revenue (TTM)

$115.66M
↓ 2.22% YoY

Trailing 12 months ending Mar 2024

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin